このページの翻訳は実験的なもので、現在開発中です。お待ちしております

Ramsay Générale de Santé 将来の成長

Future 基準チェック /06

現在、 Ramsay Générale de Santéの成長と収益を予測するのに十分なアナリストの調査がありません。

主要情報

n/a

収益成長率

n/a

EPS成長率

Healthcare 収益成長	20.3%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

更新なし

Recent updates

Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Paint A Concerning Picture

May 29

Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

Nov 19

Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

Sep 13

Ramsay Générale de Santé (EPA:GDS) Has Some Way To Go To Become A Multi-Bagger

Aug 09

Here's Why I Think Ramsay Générale de Santé (EPA:GDS) Is An Interesting Stock

Jun 02

Return Trends At Ramsay Générale de Santé (EPA:GDS) Aren't Appealing

Mar 29

If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

Feb 01

Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

Dec 05

Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

Oct 30

Is Ramsay Générale de Santé (EPA:GDS) A Risky Investment?

Oct 11

Ramsay Générale de Santé (EPA:GDS) Will Want To Turn Around Its Return Trends

Aug 31

If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

Jul 15

These 4 Measures Indicate That Ramsay Générale de Santé (EPA:GDS) Is Using Debt Extensively

Jun 15

Ramsay Générale de Santé (EPA:GDS) Will Will Want To Turn Around Its Return Trends

May 04

We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt

Mar 08

Should We Be Cautious About Ramsay Générale de Santé SA's (EPA:GDS) ROE Of 1.7%?

Feb 15

Should We Be Excited About The Trends Of Returns At Ramsay Générale de Santé (EPA:GDS)?

Jan 19

Should Ramsay Générale de Santé (EPA:GDS) Be Disappointed With Their 19% Profit?

Dec 23

Here's Why Ramsay Générale de Santé's (EPA:GDS) Statutory Earnings Are Arguably Too Conservative

Dec 03

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Ramsay Générale de Santé は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

ENXTPA:GDS - アナリストの将来予測と過去の財務データ ( )EUR Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
6/30/2024	5,007	-54	418	587	N/A
3/31/2024	4,941	-10	430	594	N/A
12/31/2023	4,862	-12	398	565	N/A
9/30/2023	4,782	19	412	582	N/A
6/30/2023	4,702	49	427	599	N/A
3/31/2023	4,594	69	280	456	N/A
12/31/2022	4,473	103	246	422	N/A
9/30/2022	4,387	111	157	342	N/A
6/30/2022	4,301	118	69	263	N/A
3/31/2022	4,225	98	7	198	N/A
12/31/2021	4,149	77	-55	133	N/A
9/30/2021	4,086	71	211	393	N/A
6/30/2021	4,023	65	476	652	N/A
3/31/2021	3,873	63	705	875	N/A
12/31/2020	3,723	61	933	1,099	N/A
9/30/2020	3,735	37	747	914	N/A
6/30/2020	3,746	13	561	730	N/A
3/31/2020	3,871	11	338	519	N/A
12/31/2019	3,996	8	116	308	N/A
9/30/2019	3,698	8	76	261	N/A
6/30/2019	3,401	8	36	214	N/A
3/31/2019	2,958	19	45	197	N/A
12/31/2018	2,515	29	54	181	N/A
9/30/2018	2,378	18	103	198	N/A
6/30/2018	2,242	7	151	214	N/A
3/31/2018	2,232	9	N/A	210	N/A
12/31/2017	2,223	10	N/A	206	N/A
9/30/2017	2,229	34	N/A	208	N/A
6/30/2017	2,234	57	N/A	209	N/A
3/31/2017	2,262	52	N/A	235	N/A
12/31/2016	2,289	47	N/A	261	N/A
9/30/2016	2,258	42	N/A	228	N/A
6/30/2016	2,227	37	N/A	196	N/A
12/31/2015	1,973	32	N/A	129	N/A
9/30/2015	1,880	21	N/A	152	N/A
6/30/2015	1,722	-3	N/A	184	N/A
12/31/2014	1,712	20	N/A	159	N/A
9/30/2014	1,734	108	N/A	179	N/A
6/30/2014	1,770	112	N/A	139	N/A
3/31/2014	1,820	115	N/A	151	N/A
12/31/2013	1,870	111	N/A	151	N/A
9/30/2013	1,886	40	N/A	163	N/A

アナリストによる今後の成長予測

収入対貯蓄率: GDSの予測収益成長が貯蓄率 ( 1.1% ) を上回っているかどうかを判断するにはデータが不十分です。

収益対市場: GDSの収益がFrench市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です

高成長収益: GDSの収益が今後 3 年間で大幅に増加すると予想されるかどうかを判断するにはデータが不十分です。

収益対市場: GDSの収益がFrench市場よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

高い収益成長: GDSの収益が年間20%よりも速く成長すると予測されるかどうかを判断するにはデータが不十分です。

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: GDSの自己資本利益率が 3 年後に高くなると予測されるかどうかを判断するにはデータが不十分です

Ramsay Générale de Santé 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Full year 2024 earnings released: €0.49 loss per share (vs €0.45 profit in FY 2023)

Ramsay Générale de Santé SA to Report Fiscal Year 2023 Results on Aug 29, 2024

Third quarter 2024 earnings released: €0.032 loss per share (vs €0.025 profit in 3Q 2023)

Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Paint A Concerning Picture

Many Still Looking Away From Ramsay Générale de Santé SA (EPA:GDS)

Ramsay Générale de Santé (EPA:GDS) Seems To Be Using A Lot Of Debt

First half 2024 earnings released: €0.16 loss per share (vs €0.40 profit in 1H 2023)

Investors Interested In Ramsay Générale de Santé SA's (EPA:GDS) Earnings

Full year 2023 earnings released: EPS: €0.45 (vs €1.07 in FY 2022)

Ramsay Générale de Santé (EPA:GDS) Has A Somewhat Strained Balance Sheet

Ramsay Générale de Santé (EPA:GDS) Is Reinvesting At Lower Rates Of Return

New minor risk - Profit margin trend

Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?

We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt

The Returns At Ramsay Générale de Santé (EPA:GDS) Aren't Growing

Is Now The Time To Put Ramsay Générale de Santé (EPA:GDS) On Your Watchlist?

Is Ramsay Générale de Santé (EPA:GDS) Using Too Much Debt?

First half 2023 earnings released: EPS: €0.40 (vs €0.54 in 1H 2022)

Returns On Capital At Ramsay Générale de Santé (EPA:GDS) Have Stalled

Does Ramsay Générale de Santé (EPA:GDS) Deserve A Spot On Your Watchlist?

Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

Less than half of directors are independent

Full year 2022 earnings released: EPS: €1.07 (vs €0.59 in FY 2021)

Ramsay Reportedly Still Weighing Options for French Stake

Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

Ramsay Générale de Santé (EPA:GDS) Has Some Way To Go To Become A Multi-Bagger

Investor sentiment deteriorated over the past week

Here's Why I Think Ramsay Générale de Santé (EPA:GDS) Is An Interesting Stock

Less than half of directors are independent

Return Trends At Ramsay Générale de Santé (EPA:GDS) Aren't Appealing

If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

Slowing Rates Of Return At Ramsay Générale de Santé (EPA:GDS) Leave Little Room For Excitement

Full year 2021 earnings released: EPS €0.59 (vs €0.12 in FY 2020)

Here's Why We Think Ramsay Générale de Santé (EPA:GDS) Is Well Worth Watching

Is Ramsay Générale de Santé (EPA:GDS) A Risky Investment?

Ramsay Générale de Santé SA (ENXTPA:GDS) acquired WeCare Holding ApS.

Ramsay Générale de Santé (EPA:GDS) Will Want To Turn Around Its Return Trends

Full year 2021 earnings released: EPS €0.59 (vs €0.12 in FY 2020)

If You Like EPS Growth Then Check Out Ramsay Générale de Santé (EPA:GDS) Before It's Too Late

These 4 Measures Indicate That Ramsay Générale de Santé (EPA:GDS) Is Using Debt Extensively

Ramsay Générale de Santé (EPA:GDS) Will Will Want To Turn Around Its Return Trends

We Think Ramsay Générale de Santé (EPA:GDS) Is Taking Some Risk With Its Debt

New 90-day low: €17.25

Should We Be Cautious About Ramsay Générale de Santé SA's (EPA:GDS) ROE Of 1.7%?

Should We Be Excited About The Trends Of Returns At Ramsay Générale de Santé (EPA:GDS)?

Should Ramsay Générale de Santé (EPA:GDS) Be Disappointed With Their 19% Profit?

Here's Why Ramsay Générale de Santé's (EPA:GDS) Statutory Earnings Are Arguably Too Conservative

Full year earnings released - EPS €0.12

New 90-day high: €18.15

Ramsay Générale de Santé SA (ENXTPA:GDS) acquired Polyclinique Du Parc Drevon from Le Groupe C2S.

Ramsay Générale de Santé SA (ENXTPA:GDS) acquired La Recouvrance.

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘